Tejnaksh Healthcare Ltd

₹ 24.4 -2.44%

18 Apr - close price

About

Tejnaksh Healthcare Limited is engaged in the business of providing hospital and healthcare services in Maharashtra with focus on clinical services, diagnostic facilities, and research. ^[1]

Key Points

Services
Super Speciality Hospital: The Co runs the Institute of Urology, Dhule a super speciality hospital that provides a comprehensive range of services from consultations and investigation to treatment of various urological problems such as kidneys, ureter, bladder, prostate, and other genital organs. It provides Laser Prostatectomy, Endourology & LASER Treatment, Dialysis Unit, Clinical Nephrology etc.
Healthcare Equipments: The Co also sells Healthcare Equipments including Radiation Free PERC Simulator, PCNL Logic Simulator, Fluoroscopy Guided Simulator, Stone Manipulation Simulator etc.
Education Institute: The Co also operates its coaching facility in Dhule. The academy aims to coach 10+2, XI and XII students for NEET, AIPMT, JEE and allied entrances. ^[1]

Website BSE

Market Cap ₹ 49.5 Cr.
Current Price ₹ 24.4
High / Low ₹ 40.0 / 22.9
Stock P/E 43.4
Book Value ₹ 10.6
Dividend Yield 0.00 %
ROCE 9.56 %
ROE 6.81 %
Face Value ₹ 5.00

Add ratio to table

Edit ratios

Pros

Company has reduced debt.

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -3.16% over past five years.
Company has a low return on equity of 10.9% over last 3 years.
Debtor days have increased from 33.6 to 64.6 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	2.50	2.19	2.33	2.08	1.95	1.76	1.86	2.17	1.65	1.65	1.92	2.06	2.10
	1.55	1.23	1.12	0.88	0.93	0.88	0.89	1.01	0.95	1.34	1.40	1.10	1.04
Operating Profit	0.95	0.96	1.21	1.20	1.02	0.88	0.97	1.16	0.70	0.31	0.52	0.96	1.06
OPM %	38.00%	43.84%	51.93%	57.69%	52.31%	50.00%	52.15%	53.46%	42.42%	18.79%	27.08%	46.60%	50.48%
	0.01	0.11	0.03	0.01	0.04	0.05	0.04	0.05	0.04	0.10	0.07	0.08	0.07
Interest	0.12	0.12	0.08	0.11	0.10	0.19	0.14	0.15	0.15	0.18	0.17	0.17	0.20
Depreciation	0.16	0.15	0.14	0.14	0.14	0.16	0.20	0.20	0.20	0.20	0.20	0.20	0.20
Profit before tax	0.68	0.80	1.02	0.96	0.82	0.58	0.67	0.86	0.39	0.03	0.22	0.67	0.73
Tax %	11.76%	26.25%	25.49%	26.04%	25.61%	25.86%	25.37%	25.58%	25.64%	333.33%	27.27%	25.37%	24.66%
	0.61	0.60	0.76	0.72	0.61	0.43	0.50	0.65	0.30	-0.07	0.16	0.50	0.55
EPS in Rs	0.30	0.30	0.37	0.35	0.30	0.21	0.25	0.32	0.15	-0.03	0.08	0.25	0.27
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
	1.30	1.14	1.44	2.01	4.75	6.53	8.62	13.96	11.50	8.56	8.12	7.34	7.73
	0.78	0.55	0.49	1.04	2.45	3.67	4.37	10.34	7.93	4.96	3.76	4.21	4.88
Operating Profit	0.52	0.59	0.95	0.97	2.30	2.86	4.25	3.62	3.57	3.60	4.36	3.13	2.85
OPM %	40.00%	51.75%	65.97%	48.26%	48.42%	43.80%	49.30%	25.93%	31.04%	42.06%	53.69%	42.64%	36.87%
	0.02	0.00	0.01	0.04	0.03	0.20	0.43	1.42	0.48	0.14	0.08	0.24	0.32
Interest	0.01	0.00	0.00	0.00	0.00	0.19	0.96	0.77	0.80	0.54	0.48	0.62	0.72
Depreciation	0.10	0.11	0.11	0.14	0.21	0.34	0.44	0.52	0.59	0.61	0.59	0.79	0.80
Profit before tax	0.43	0.48	0.85	0.87	2.12	2.53	3.28	3.75	2.66	2.59	3.37	1.96	1.65
Tax %	32.56%	35.42%	32.94%	32.18%	37.74%	33.20%	26.22%	28.27%	27.44%	22.39%	25.22%	30.10%
	0.30	0.31	0.57	0.60	1.32	1.69	2.43	2.69	1.92	2.00	2.52	1.38	1.14
EPS in Rs				0.41	0.65	0.84	1.20	1.33	0.95	0.99	1.24	0.68	0.57
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	20%
5 Years:	-3%
3 Years:	-14%
TTM:	4%

Compounded Profit Growth
10 Years:	16%
5 Years:	-11%
3 Years:	-10%
TTM:	-39%

Stock Price CAGR
10 Years:	%
5 Years:	-1%
3 Years:	-10%
1 Year:	-33%

Return on Equity
10 Years:	16%
5 Years:	13%
3 Years:	11%
Last Year:	7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	0.01	0.01	0.01	0.80	1.10	2.21	2.21	10.16	10.16	10.16	10.16	10.16	10.16
Reserves	1.00	1.31	1.88	1.69	5.14	5.73	8.19	2.93	4.85	6.87	9.40	10.79	11.45
	0.37	0.36	0.47	0.00	0.00	6.39	7.64	6.33	7.25	4.93	7.03	6.45	5.61
	0.30	0.33	0.62	1.04	0.60	0.55	1.13	1.99	2.02	1.92	2.09	2.40	2.98
Total Liabilities	1.68	2.01	2.98	3.53	6.84	14.88	19.17	21.41	24.28	23.88	28.68	29.80	30.20
	1.40	1.37	1.43	2.86	3.34	13.43	14.54	16.19	16.59	14.34	14.55	22.51	23.34
CWIP	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.39	0.65	0.79	8.89	0.95	0.01
Investments	0.00	0.00	0.00	0.01	2.59	0.07	1.06	1.06	1.06	1.06	1.06	1.06	1.06
	0.28	0.64	1.55	0.65	0.91	1.38	3.57	3.77	5.98	7.69	4.18	5.28	5.79
Total Assets	1.68	2.01	2.98	3.53	6.84	14.88	19.17	21.41	24.28	23.88	28.68	29.80	30.20

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	0.09	0.11	0.08	1.71	3.67	1.78	3.88	3.15	1.00	0.84	9.13	1.90
	-0.31	-0.08	-0.17	-1.59	-3.26	-7.91	-2.59	-1.49	-1.16	1.56	-10.40	-0.98
	0.00	-0.01	0.11	-0.04	-0.13	6.39	-0.64	-2.08	0.22	-2.86	1.61	-1.17
Net Cash Flow	-0.22	0.02	0.02	0.08	0.29	0.26	0.64	-0.42	0.06	-0.47	0.35	-0.25

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.75	16.82	15.78	20.23	64.65
Inventory Days					98.06	86.45	126.74		182.50	340.67	251.90	142.64
Days Payable					114.40	134.47	177.43		143.79	129.78	77.11	117.47
Cash Conversion Cycle	0.00	0.00	0.00	0.00	-16.34	-48.03	-50.69	5.75	55.53	226.67	195.02	89.82
Working Capital Days	-2.81	102.46	240.80	-5.45	-1.54	19.56	-5.93	24.58	105.37	9.81	-13.93	57.68
ROCE %	35.77%	31.37%	42.08%	36.29%	48.57%	26.45%	26.20%	24.13%	16.60%	14.20%	16.07%	9.56%

Shareholding Pattern

Numbers in percentages

5 Recently

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	73.84%	73.84%	73.83%	73.83%	73.83%	73.84%	73.84%	73.83%	73.83%	73.83%	73.83%	73.83%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.58%	0.58%	0.58%	0.58%	0.28%
	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	26.15%	26.16%	26.17%	26.17%	26.17%	26.16%	26.16%	25.59%	25.57%	25.58%	25.60%	25.89%
No. of Shareholders	908	990	974	998	967	994	1,041	1,445	1,636	2,628	3,057	3,502

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	72.46%	72.46%	72.90%	73.82%	73.84%	73.83%	73.83%	73.83%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.58%	0.28%
	0.58%	1.36%	0.80%	0.75%	0.01%	0.00%	0.00%	0.00%
	26.96%	26.18%	26.30%	25.42%	26.15%	26.17%	25.59%	25.89%
No. of Shareholders	112	148	320	341	732	998	1,445	3,502

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Feb 2018

Transcript

Notes
PPT